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Probiotic Bifidobacterium longum subspecies infantis (Bi®dobacter-
ium infantis) consumes human milk oligosaccharides (MO) and
protects intestinal permeability thereby having anti-inflammatory
effects (Underwood et al., 2015; Bode, 2006; Asakuma et al., 2011)
[1–3]. Via the gut-liver axis, gut barrier disruption and dysbiosis
lead to hepatic inflammation (Sheng et al., 2017; Jena et al., 2017)
[4,5,6]. Our published data revealed that butyrate, as well as syn-
biotics of B. infantis in combination with MO, had protective effects
against cancer-prone non-alcoholic steatohepatitis (NASH) mouse
models, i.e., Western diet (WD)-fed bile acid receptor FXR (farne-
soid x receptor) knockout (KO) mice (Jena et al., 2018) [6,7]. In
addition, MO was particularly effective in increasing the blooming
of butyrate-generating bacteria (Jena et al., 2018) [7]. In the pre-
sent study, we further showed that the reduced ileal short chain
fatty acid (SCFA) signaling found in WD-fed FXR KO mice could be
reversed by B. infantis and/or MO treatment. Moreover, ileal mRNA
levels of SCFA receptors i.e. Gpr41 (Ffar3), Gpr109 (Hcar2), and
Gpr43 (Ffar2) were increased in B. infantis and/or MO-treated micevier Inc. This is an open access article under the CC BY license
.jnutbio.2018.04.007
and Laboratory Medicine, University of California, Davis Health Systems,
Sacramento, CA 95817, USA. Fax: þ1 916 734-3787.
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P.K. Jena et al. / Data in Brief 19 (2018) 1025–10291026suggesting increased SCFA signaling (Fig. 1). Further, nuclear
magnetic resonance (NMR) data revealed that MO and B. Infantis
plus MO increased intestinal acetate, propionate, butyrate, and
valerate levels (Fig. 2). In addition, B. infantis and/or MO reduced
the abundance of genus Bilophila and the relative copy number of
bacterial genes including dissimilatory sulfite reductase (dsrA) and
methyl coenzyme M reductase A (mcrA), which were all increased
in cancer-prone FXR KO mice (Fig. 3).
& 2018 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Specifications Tableubject area Biology, Microbiology, Molecular Biology
ore specific subject area Synbiotics
ype of data Table, figure, graph
ow data was acquired Real time PCR, NMR
ata format Analyzed
xperimental factors C57BL/6 wild type and FXR KO male mice were fed with Western diet
after weaning. When mice were 3-month old, they were given B. infantis
(109 cfu per mouse, orally, once a week) in saline, bovine MO (7% in a diet
that lacks 7%
cellulose), or a combination of B. infantis plus MO while mice continued a
WD for 7 months and euthanized when they were 10-month old.xperimental features Gene expression in ileum and SCFA concentration in cecal content were
measured by real time PCR and NMR, respectively.ata source location Sacramento, California, United States of America
ata accessibility Data with this articleValue of the data
– In our earlier report, B. infantis and MO treatment reduced hepatic and ileal inflammation [7]. It has
been shown that B. infantis and MO protects from gut barrier function and inflammation [1–3]. In
addition, the abundance of bacterial butyrate-generating genes bcoA (butyryl-CoA: acetate CoA-
transferase) and buk (butyrate kinase) in the cecum was increased with MO and B. infantis plus MO
treatment. Data in this study described the mRNA expression of SCFA receptors regulated by
B. infantis and MO treatment. Our data showed that increased SCFA signaling with B. infantis and
MO treatment was associated with reduced inflammation.
– In our earlier report, the concentration of butyrate was reduced in FXR KO mice [6]. Data in this study
described that B. infantis and MO increased SCFAs, i.e., acetate, propionate, butyrate, and valerate.
Additionally, such increases were accompanied by reduced inflammation in FXR KO mice. It has been
shown that dysregulated bile acid and gut dysbiosis causes hepatic inflammation [4–7]. Moreover,
the abundance of genus Bilophila and dsrA gene, which are involved in the generation of hydrogen
sulfide, was increased by FXR inactivation and B. infantis and MO treatment reversed those changes.
– These data suggested that the anti-inflammatory effect of B. infantis and MO may due to increased
SCFAs and reduced hydrogen sulfide and methane.
P.K. Jena et al. / Data in Brief 19 (2018) 1025–1029 10271. Data
The data showed the mRNA level of ileal SCFA receptors i.e. Gpr41, Gpr109a, and Gpr43 in WD-fed
wild type (WT) mice and WD-fed FXR KO mice supplemented with or without Bifidobacterium infantis
and/or MO (Fig. 1). NMR data generated from cecal content showed the concentration of acetate,
propionate, butyrate, and valerate (Fig. 2). Moreover, bacteria and their functional genes were
determined by real-time quantitative PCR (Fig. 3).2. Experimental design
2.1. Mice
Specific pathogen-free male C57BL/6 WT mice (Jackson Laboratory, Sacramento, CA, USA) and FXR
KO mice were housed in steel microisolator cages at 22 °C with a 12-h light/dark cycle. They were
given a WD containing 21.2% fat, 34% sucrose, and 0.2% cholesterol (Envigo, Indianapolis, IN, USA)
right after weaning (3 weeks, 6–10 mice per group). When mice were 3-month old, they were given B.
infantis (109 cfu per mouse, orally, once a week) in saline, bovine MO (7% in a diet that lacks 7%Fig. 2. NMR analysis of SCFA concentration in cecal content of WD-fed WT mice and WD-fed FXR KO mice treated with and
without B. infantis and/or MO. Data expressed as mean7SD. n Z 6 per group. *po 0.05. WT mice compared with FXR KO
mice, and untreated FXR KO mice compared with treated FXR KO mice.
Fig. 1. The effects of B. infantis and/or MO on SCFA receptor signaling. Ileal mRNA level of indicated genes in WD-fed WT mice
andWD-fed FXR KO mice supplemented with and without B. infantis and/or MO for 7 months. Data expressed as mean 7 SD. n
Z 6 per group. *po 0.05, **po 0.01. WT mice compared with FXR KO mice, and untreated FXR KO mice compared with
treated FXR KO mice on the same diet.
Fig. 3. Targeted functional quantitative PCR analyses of microbial genes in WD-fed WT mice and WD-fed FXR KO mice
supplemented with and without B. infantis and/or MO. Data expressed as mean7SD. n Z 6 per group. *po 0.05, **po 0.01,
***po 0.001, WT mice compared with FXR KO mice, and untreated FXR KO mice compared with treated FXR KO mice.
Table 1
Primers used for qPCR.
Gene Forward (5’ – 3’) Reverse (5’ – 3’)
qPCR primers used to quantify gene expression in mice
Gpr41 GTGACCATGGGGACAAGCTTC CCCTGGCTGTAGGTTGCATT
Gpr109a ATGGCGAGGCATATCTGTGTAGCA TCCTGCCTGAGCAGAACAAGATGA
Gpr43 GGCTTCTACAGCAGCATCTA AAGCACACCAGGAAATTAAG
qPCR primers used to quantify bacterial genes
Bilophila (tpA) CGGTATCGAAATCGTGAAGG CAGAGGGTCAGGGTGTTGTT
dsrA GCCGTTACTGTGACCAGCC GGTGGAGCCGTGCATGTT
mcrA TTCGGTGGATCDCARAGRGC GBARGTCGWAWCCGTAGAATCC
P.K. Jena et al. / Data in Brief 19 (2018) 1025–10291028cellulose), or a combination of B. infantis plus MO while mice continued a WD until they were
10-month old. Experiments were conducted in accordance with the National Institutes of Health
Guidelines for the Care and Use of Laboratory Animals under protocols approved by the Institutional
Animal Care and Use Committee of the University of California, Davis.
2.2. Gene expression and quantification of bacterial genes
RNA was isolated from mouse tissues using TRIzol (Invitrogen, Carlsbad, CA, USA) and reverse
transcribed into cDNA. qRT-PCR was performed on an ABI 7900HT Fast real-time PCR system using
Power SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA, USA). The mRNA levels were
normalized to the level of Gapdh mRNA. The primer sets used are described in Table 1.
For bacterial gene quantification, cecal (0.05 g) DNA was extracted using ZR Fecal DNA MiniPrep
Kit (Zymo Research, Irvine, CA, USA), quantified by NanoDrop (Thermo Scientific, Wilmington, DE,
USA), and amplified using primers listed in Table 1. A dissociation step was included to analyze the
melting profile of amplified products. In parallel, qPCR was performed using ten-fold serial diluted
synthetic DNA fragments (Integrative DNA technologies, Redwood city, CA, USA) of a bacterial gene
with known concentrations. Bacterial DNA concentration was calculated using standard curves of
diluted synthetic DNA fragment based on method described elsewhere [8].
2.3. 1H NMR spectroscopy for metabolic profiling
Cecal samples (5060mg) were prepared and analyzed by 1H NMR based on published method
[6,9]. Each cecal sample was homogenized and mixed with sodium-potassium phosphate buffer and
centrifuged at 14,000g for 20min. All 1H NMR spectra were collected using a Bruker advance 600
P.K. Jena et al. / Data in Brief 19 (2018) 1025–1029 1029NMR spectrometer (Bruker; Rheinstetten, Germany). The samples were pre-cooled to 277 K before
being loaded into the magnet, and were warmed to 298 K and equilibrated for 5min before data
acquisition. For each sample, 64 scans were collected into 64 K data points over a spectral width of 20
ppmwith a relaxation delay of 2 s. Identification and quantification of metabolites were accomplished
using Chenomx NMR Suite 7.6 (Chenomx, Inc., Edmonton, Alberta, Canada).
2.4. Statistical analysis
Data are presented as the mean 7 SD. Statistical analysis was performed by unpaired Student's
t-test or one-way analysis of variance by using GraphPad Prism 6.0 (GraphPad, La Jolla, CA, USA).
P o 0.05 was considered statistically significant.Acknowledgements
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